Takeuchi T, Chino Y, Kawanishi M, Nakanishi M, et al. Efficacy and pharmacokinetics of ozoralizumab, an anti-TNFalpha NANOBODY((R)) compound, in patients with rheumatoid arthritis: 52-week results from the OHZORA and NATSUZORA trials. Arthritis Res Ther 2023;25:60.
PMID: 37055803